6 Research & Reports stories on the commercial real estate wire for July 8, 2026, spanning Dallas, Chicago, Miami, New York. Each links to its original source.
PR Newswire · Dallas
Lennox Schedules Second Quarter Results
DALLAS, July 8, 2026 /PRNewswire/ -- Lennox (NYSE: LII), a leader in energy-efficient building and home comfort solutions, will report second quarter 2026 financial results before the market opens on Wednesday, July 2…
Architect Financial Technologies Partners with Compute Desk to Launch Exchange-for-Physical Market for GPU Compute
CHICAGO, July 8, 2026 /PRNewswire/ -- Architect Financial Technologies Inc. ("Architect" or "the Company") today announced a partnership with The Compute Index, Inc. ("Compute Desk") to launch the US financial industr…
Flacks Group's Billionaire Investor Behind 10,000 Preserved Jobs Targets Europe's Largest Steel Turnaround
MIAMI, July 8, 2026 /PRNewswire/ -- Michael Flacks, founder and chairman of Flacks Group, has entered the top 100 of the Sunday Times Rich List, ranking #98 in 2026 with an estimated net worth of £1.681 billion. The r…
Precision Biotics Market worth $9.26 billion by 2031- Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., July 8, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the precision biotics market is projected to grow from USD 4.91 billion in 2026 and to reach USD 9.26 billion by 2031, at a Compound An…
OneMain Holdings Announces Date of Second Quarter 2026 Earnings Release and Conference Call
NEW YORK, July 8, 2026 /PRNewswire/ -- OneMain Holdings, Inc. (NYSE: OMF), the leader in offering nonprime consumers responsible access to credit, plans to report its second quarter 2026 results before the market open…
Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia
The study shows that ISLV-directed delivery of the MMUT gene produced durable therapeutic benefits in mouse models. Gene transfer efficiency exceeded 80% of the liver. Genespire is progressing its lead asset for MMA,…